4.2 Article

Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Effect of mutated IκBα transfection on multidrug resistance in hilar cholangiocarcinoma cell lines

Ru-Fu Chen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)